Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: About RG on LinkedIn

That said, Crossflo has invoiced initial revenues on several key projects within the government agency, state law enforcement, healthcare (in conjunction with Hewlett-Packard (HP)) and other public sector applications, such as a large statewide court system. It is the potential of these and follow-on opportunities, the strength of the HP partnership, and the initial traction Crossflo has achieved at an early stage of public sector and healthcare data sharing, which provided the basis for our valuation of the Company. Each of these markets represents multi-billion dollar revenue opportunities for database integration software. We expect Crossflo to have a profitable 2009 plan with more specifics released before year-end.

Avot has recently contracted with several major international carriers to perform field trials that are in progress or will be launched before the end of 2008. Avot has recently expanded its sales channel coverage in Europe and Asia.

Perhaps the Japan/Asia activities were as director of Avot?

.

.

.

Be well

Share
New Message
Please login to post a reply